Skip to content
Sermo
  • Newsroom
    • News Articles
    • Press Releases
    • Barometer Releases
    • Methodology
  • About
    • Member Reviews
    • Medical Advisory Board
    • Careers
    • Health Equity at Sermo
    • Peter’s Cancer Story
  • Blog
  • Physician Resources
    • Physician surveys
    • Continuing Medical Education
    • Ethical issues in healthcare
    • 7 bedside manner techniques for oncologists
    • Innovative insights into the path towards a cancer cure
    • Are physician surveys worth it for oncologists? 
  • Log in
  • Sign up
Newsroom

Press Releases

  • News Articles
  • Press Releases
  • Barometer Releases
  • Methodology
February 3, 2010, Cambridge, MA

Tasigna front line data strong; but won’t displace gleevec

Oncologists on Sermo Positive About New Findings in CML but Looking for More Data points

January 19, 2010, Cambridge, MA

Religion is a popular topic among US physicians on Sermo

Physicians Nationwide Debate Existence of Afterlife

January 10, 2010, Cambridge, MA

Mayo Clinic of Arizona to drop Medicare for primary care

Physicians Nationwide React to Announcement that Mayo Clinic of Arizona Will Stop Accepting Medicare Patients

January 5, 2010, Cambridge, MA

Neurologists eagerly await Cladribine and Fingolimod

Majority of Neurologists need more long-term safety data before prescribing oral MS agents as first line therapy

December 16, 2009, Cambridge, MA

Sermo quantifies 1 year of physician thoughts on diabetes

Social Media Analysis Uncovers Preferred Medications, Most Discussed Therapies, Physician Concerns about Lifestyle Coaching, and Affordability Issues

« Previous Page1 … Page10 Page11 Page12 Page13
Sermo

Sermo

  • About
  • Careers
  • Newsroom
  • Health Equity at Sermo
  • Member Reviews
  • Social Network for Doctors
  • Contact Us

Business

  • Physician Insights
  • Physician Engagement
  • Quality Guaranteed

Resources

  • Support
  • Blog
  • COVID-19 Barometer
  • HCP Sentiment Studies
  • HCP Marketing
  • Medical Market Research Surveys

Quality & Compliance

  • Privacy Policy
  • Terms of Service
  • Code of Conduct
  • Privacy Inquiries
Copyright © 2023 Sermo

Follow Sermo

  • Facebook
  • Twitter
  • Linkedin